Perivascular osteoprogenitors are associated with transcortical channels of long bones.


Journal

Stem cells (Dayton, Ohio)
ISSN: 1549-4918
Titre abrégé: Stem Cells
Pays: England
ID NLM: 9304532

Informations de publication

Date de publication:
06 2020
Historique:
received: 21 10 2019
accepted: 23 01 2020
pubmed: 14 2 2020
medline: 8 5 2021
entrez: 14 2 2020
Statut: ppublish

Résumé

Bone remodeling and regeneration are dependent on resident stem/progenitor cells with the ability to replenish mature osteoblasts and repair the skeleton. Using lineage tracing approaches, we identified a population of Dmp1+ cells that reside within cortical bone and are distinct from osteocytes. Our aims were to characterize this stromal population of transcortical perivascular cells (TPCs) in their resident niche and evaluate their osteogenic potential. To distinguish this population from osteoblasts/osteocytes, we crossed mice containing inducible DMP1CreERT2/Ai9 Tomato reporter (iDMP/T) with Col2.3GFP reporter (ColGFP), a marker of osteoblasts and osteocytes. We observed iDMP/T+;ColGFP- TPCs within cortical bone following tamoxifen injection. These cells were perivascular and located within transcortical channels. Ex vivo bone outgrowth cultures showed TPCs migrated out of the channels onto the plate and expressed stem cell markers such as Sca1, platelet derived growth factor receptor beta (PDGFRβ), and leptin receptor. In a cortical bone transplantation model, TPCs migrate from their vascular niche within cortical bone and contribute to new osteoblast formation and bone tube closure. Treatment with intermittent parathyroid hormone increased TPC number and differentiation. TPCs were unable to differentiate into adipocytes in the presence of rosiglitazone in vitro or in vivo. Altogether, we have identified and characterized a novel stromal lineage-restricted osteoprogenitor that is associated with transcortical vessels of long bones. Functionally, we have demonstrated that this population can migrate out of cortical bone channels, expand, and differentiate into osteoblasts, therefore serving as a source of progenitors contributing to new bone formation.

Identifiants

pubmed: 32053258
doi: 10.1002/stem.3159
pmc: PMC7768989
mid: NIHMS1655374
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-781

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR055607
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR070813
Pays : United States

Informations de copyright

©AlphaMed Press 2020.

Références

Nat Metab. 2019 Feb;1(2):236-250
pubmed: 31620676
Bone. 2004 Jul;35(1):74-82
pubmed: 15207743
J Bone Miner Res. 2012 Oct;27(10):2075-84
pubmed: 22623172
J Bone Miner Res. 2002 Jan;17(1):15-25
pubmed: 11771662
Nature. 2010 Aug 12;466(7308):829-34
pubmed: 20703299
J Immunol. 2005 May 15;174(10):6477-89
pubmed: 15879151
Cell Stem Cell. 2012 Mar 2;10(3):259-72
pubmed: 22385654
J Endocrinol. 2011 Apr;209(1):21-32
pubmed: 21220409
Stem Cells. 2016 Dec;34(12):2930-2942
pubmed: 27507737
Cell Metab. 2013 Nov 5;18(5):749-58
pubmed: 24140021
Cell Stem Cell. 2008 Sep 11;3(3):301-13
pubmed: 18786417
Bone. 2013 Jun;54(2):296-306
pubmed: 23072918
J Bone Miner Res. 2019 Aug;34(8):1487-1501
pubmed: 30920026
J Dent Res. 2007 Apr;86(4):320-5
pubmed: 17384025
Dev Cell. 2005 May;8(5):727-38
pubmed: 15866163
Dev Cell. 2014 May 12;29(3):340-9
pubmed: 24823377
Cell. 2015 Jan 15;160(1-2):269-84
pubmed: 25594183
Cell. 1997 May 30;89(5):765-71
pubmed: 9182764
J Exp Med. 2009 Oct 26;206(11):2483-96
pubmed: 19841085
Dev Biol. 2004 May 1;269(1):55-69
pubmed: 15081357
J Bone Miner Res. 2012 Feb;27(2):374-89
pubmed: 22028311
Nat Neurosci. 2010 Jan;13(1):133-40
pubmed: 20023653
Cell Stem Cell. 2014 Aug 7;15(2):154-68
pubmed: 24953181
Development. 2005 Mar;132(5):1057-67
pubmed: 15689378
Stem Cells Int. 2019 Jan 17;2019:9838167
pubmed: 30800165
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Front Neuroanat. 2015 Feb 24;9:19
pubmed: 25759641
PLoS One. 2013 Sep 06;8(9):e75204
pubmed: 24040401
Bone. 2013 Apr;53(2):575-86
pubmed: 23274348
Nature. 2018 Oct;562(7725):133-139
pubmed: 30250253
Nat Commun. 2017 Dec 11;8(1):2043
pubmed: 29230039
J Bone Miner Res. 2019 Jun;34(6):979-995
pubmed: 30882939
J Bone Miner Res. 2014;29(5):1283-94
pubmed: 24190076
Cell. 2007 Oct 19;131(2):324-36
pubmed: 17956733
Dev Cell. 2010 Aug 17;19(2):329-44
pubmed: 20708594
Bone. 2015 Jul;76:129-40
pubmed: 25794783
Calcif Tissue Int. 2018 Dec;103(6):625-637
pubmed: 30019315
J Bone Miner Res. 2001 Dec;16(12):2222-31
pubmed: 11760835
Bone. 2008 Sep;43(3):501-10
pubmed: 18571490
Cell. 2002 Jan 11;108(1):17-29
pubmed: 11792318
Cell. 1997 May 30;89(5):755-64
pubmed: 9182763
Mech Dev. 2002 Feb;111(1-2):61-73
pubmed: 11804779
J Vis Exp. 2016 Sep 14;(115):
pubmed: 27684089
Nat Protoc. 2010 Mar;5(3):550-60
pubmed: 20203670
Neuroscience. 2018 Sep 1;387:178-190
pubmed: 29432884
J Bone Miner Res. 2019 Oct;34(10):1952-1963
pubmed: 31173642
J Bone Miner Res. 2016 Nov;31(11):2001-2007
pubmed: 27237054
Bone Res. 2017 Jan 31;5:16049
pubmed: 28163952
Stem Cells. 2012 Feb;30(2):187-96
pubmed: 22083974

Auteurs

Sierra H Root (SH)

Department of Reconstructive Sciences, UConn Health, Farmington, Connecticut, USA.

Natalie K Y Wee (NKY)

Department of Reconstructive Sciences, UConn Health, Farmington, Connecticut, USA.

Sanja Novak (S)

Department of Reconstructive Sciences, UConn Health, Farmington, Connecticut, USA.

Clifford J Rosen (CJ)

Department of Medicine, Tufts University School of Medicine, Maine Medical Center Research Institute, Scarborough, Maine, USA.

Roland Baron (R)

Department of Oral Medicine, Infection and Immunity, Division of Bone and Mineral Research, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Brya G Matthews (BG)

Department of Reconstructive Sciences, UConn Health, Farmington, Connecticut, USA.
Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.

Ivo Kalajzic (I)

Department of Reconstructive Sciences, UConn Health, Farmington, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH